133 related articles for article (PubMed ID: 2405921)
1. In vivo hematologic effects of recombinant human macrophage colony-stimulating factor.
Ulich TR; del Castillo J; Watson LR; Yin SM; Garnick MB
Blood; 1990 Feb; 75(4):846-50. PubMed ID: 2405921
[TBL] [Abstract][Full Text] [Related]
2. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
3. The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation.
Ulich TR; del Castillo J; Guo K; Souza L
Am J Pathol; 1989 Jan; 134(1):149-59. PubMed ID: 2464282
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia.
Ulich TR; del Castillo J; Souza L
Am J Pathol; 1988 Dec; 133(3):630-8. PubMed ID: 2462357
[TBL] [Abstract][Full Text] [Related]
5. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.
Munn DH; Garnick MB; Cheung NK
Blood; 1990 May; 75(10):2042-8. PubMed ID: 2186820
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.
Ulich TR; del Castillo J; Keys M; Granger GA; Ni RX
J Immunol; 1987 Nov; 139(10):3406-15. PubMed ID: 3316383
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human alpha lymphotoxin (tumor necrosis factor-beta) induces peripheral neutrophilia and lymphopenia in the rat.
Ulich TR; del Castillo J; Keys M; Granger GA
Am J Pathol; 1987 Jul; 128(1):5-12. PubMed ID: 3496795
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
[TBL] [Abstract][Full Text] [Related]
9. Acute in vivo effects of IL-3 alone and in combination with IL-6 on the blood cells of the circulation and bone marrow.
Ulich TR; del Castillo J; Busser K; Guo KZ; Yin SM
Am J Pathol; 1989 Oct; 135(4):663-70. PubMed ID: 2801884
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of tumor necrosis factor alpha-induced lymphopenia, neutropenia, and biphasic neutrophilia: a study of lymphocyte recirculation and hematologic interactions of TNF alpha with endogenous mediators of leukocyte trafficking.
Ulich TR; del Castillo J; Ni RX; Bikhazi N; Calvin L
J Leukoc Biol; 1989 Feb; 45(2):155-67. PubMed ID: 2492593
[TBL] [Abstract][Full Text] [Related]
11. Recombinant tumor necrosis factor enhances the proliferative responsiveness of murine peripheral macrophages to macrophage colony-stimulating factor but inhibits their proliferative responsiveness to granulocyte-macrophage colony-stimulating factor.
Chen BD; Mueller M
Blood; 1990 Apr; 75(8):1627-32. PubMed ID: 2183886
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
13. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
Cairo MS; Plunkett JM; Mauss D; Van de ven C
Blood; 1990 Nov; 76(9):1788-94. PubMed ID: 1699622
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
[TBL] [Abstract][Full Text] [Related]
15. A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSF.
Hammond WP; Boone TC; Donahue RE; Souza LM; Dale DC
Blood; 1990 Aug; 76(3):523-32. PubMed ID: 1696146
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer.
Cole DJ; Sanda MG; Yang JC; Schwartzentruber DJ; Weber J; Ettinghausen SE; Pockaj BA; Kim HI; Levin RD; Pogrebniak HW
J Natl Cancer Inst; 1994 Jan; 86(1):39-45. PubMed ID: 8271281
[TBL] [Abstract][Full Text] [Related]
17. Effect in vivo of multiple injections of purified murine and recombinant human macrophage colony-stimulating factor to mice.
Chikkappa G; Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Greenberg ML; Waheed A; Shadduck RK
Cancer Res; 1989 Jul; 49(13):3558-61. PubMed ID: 2659162
[TBL] [Abstract][Full Text] [Related]
18. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man.
Linch DC; Devereux S; Addison IE
Behring Inst Mitt; 1988 Aug; (83):320-3. PubMed ID: 3071347
[TBL] [Abstract][Full Text] [Related]
19. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.
Sullivan GW; Carper HT; Mandell GL
Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
